Universität zu Köln

Von Lilienfeld-Toal, Marie, Vehreschild, Joerg Janne, Cornely, Oliver, Pagano, Livio, Compagno, Francesca, Hirsch, Hans H. ORCID: 0000-0003-0883-0423, Pagliuca, Antonio, Akan, Hamdi, Lagrou, Katrin, Hoenigl, Martin ORCID: 0000-0002-1653-2824, Klimko, Nikolai, Verweij, Paul, Duarte, Rafael, Zimmerli, Stefan, Bretagne, Stephane and Racil, Zdenek (2020). Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases. Leukemia, 34 (6). S. 1487 - 1495. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Full text not available from this repository.

Abstract

Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems worldwide. Patients with malignant diseases are assumed to be at increased risk for a worse outcome of SARS-CoV-2 infection, and therefore, guidance regarding prevention and management of the infection as well as safe administration of cancer-therapy is required. Here, we provide recommendations for the management of patients with malignant disease in the times of COVID-19. These recommendations were prepared by an international panel of experts and then consented by the EHA Scientific Working Group on Infection in Hematology. The primary aim is to enable clinicians to provide optimal cancer care as safely as possible, since the most important protection for patients with malignant disease is the best-possible control of the underlying disease.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Von Lilienfeld-Toal, Marie UNSPECIFIED UNSPECIFIED UNSPECIFIED Vehreschild, Joerg Janne UNSPECIFIED UNSPECIFIED UNSPECIFIED Cornely, Oliver UNSPECIFIED UNSPECIFIED UNSPECIFIED Pagano, Livio UNSPECIFIED UNSPECIFIED UNSPECIFIED Compagno, Francesca UNSPECIFIED UNSPECIFIED UNSPECIFIED Hirsch, Hans H. UNSPECIFIED orcid.org/0000-0003-0883-0423 UNSPECIFIED Pagliuca, Antonio UNSPECIFIED UNSPECIFIED UNSPECIFIED Akan, Hamdi UNSPECIFIED UNSPECIFIED UNSPECIFIED Lagrou, Katrin UNSPECIFIED UNSPECIFIED UNSPECIFIED Hoenigl, Martin UNSPECIFIED orcid.org/0000-0002-1653-2824 UNSPECIFIED Klimko, Nikolai UNSPECIFIED UNSPECIFIED UNSPECIFIED Verweij, Paul UNSPECIFIED UNSPECIFIED UNSPECIFIED Duarte, Rafael UNSPECIFIED UNSPECIFIED UNSPECIFIED Zimmerli, Stefan UNSPECIFIED UNSPECIFIED UNSPECIFIED Bretagne, Stephane UNSPECIFIED UNSPECIFIED UNSPECIFIED Racil, Zdenek UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-335771
DOI:	10.1038/s41375-020-0832-y
Journal or Publication Title:	Leukemia
Volume:	34
Number:	6
Page Range:	S. 1487 - 1495
Date:	2020
Publisher:	NATURE PUBLISHING GROUP
Place of Publication:	LONDON
ISSN:	1476-5551
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language RESPIRATORY SYNCYTIAL VIRUS; WORKING PARTY AGIHO; EUROPEAN CONFERENCE; ADVERSE EVENTS; GERMAN SOCIETY; GUIDELINES; COVID-19; INFECTIONS; ECIL; RUXOLITINIB Multiple languages Oncology; Hematology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/33577